I was just mentioning how VPRO said they were hoping for $6.9 million in revenue over next three years. 170 million shares O/S, divided by $2.3 million per year in sales....VPRO selling for 75 times sales. I think most drug companies sell for two to three times sales max. just making some valuation observations....